DongKoo Bio&Pharma Co. Ltd (006620) — Free Cash Flow Generation Index
DongKoo Bio&Pharma Co. Ltd (006620) has a Free Cash Flow Generation Index of -2.06x as of September 2025. Free cash flow of ₩-2.47 Billion represents -2% of operating cash flow (₩1.20 Billion). See how liquid is DongKoo Bio&Pharma Co. Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
DongKoo Bio&Pharma Co. Ltd Free Cash Flow Generation Index (2015–2024)
Historical FCF Generation Index trend for DongKoo Bio&Pharma Co. Ltd across 9 annual periods. Explore DongKoo Bio&Pharma Co. Ltd (006620) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for DongKoo Bio&Pharma Co. Ltd (2015–2024)
Year-by-year Free Cash Flow Generation Index for DongKoo Bio&Pharma Co. Ltd. For the full company profile including market capitalisation, see DongKoo Bio&Pharma Co. Ltd (006620) market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.47x | ₩-8.12 Billion | ₩17.34 Billion | ₩25.46 Billion | ▲ +86.4% |
| 2023 | -3.45x | ₩-12.38 Billion | ₩3.59 Billion | ₩15.97 Billion | ▼ -1111.1% |
| 2022 | 0.34x | ₩5.74 Billion | ₩16.82 Billion | ₩11.08 Billion | ▼ -50.8% |
| 2021 | 0.69x | ₩12.43 Billion | ₩17.90 Billion | ₩4.27 Billion | ▲ +156.3% |
| 2020 | 0.27x | ₩2.03 Billion | ₩7.49 Billion | ₩5.27 Billion | ▲ +208.5% |
| 2019 | -0.25x | ₩-2.53 Billion | ₩10.14 Billion | ₩8.77 Billion | ▼ -123.0% |
| 2017 | 1.09x | ₩10.32 Billion | ₩9.51 Billion | ₩810.51 Million | ▼ -28.6% |
| 2016 | 1.52x | ₩19.14 Billion | ₩12.59 Billion | ₩6.55 Billion | ▲ +14.0% |
| 2015 | 1.33x | ₩9.25 Billion | ₩6.93 Billion | ₩2.32 Billion | — |